Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 15;67(8):440-443.
doi: 10.51620/0869-2084-2022-67-8-440-443.

Chromogranin B in blood serum of patients with neuroendocrine tumors

Nina Vasilyevna Lyubimova  1 , Yu S Timofeev  1 , A A Markovich  1 , A V Lebedeva  1 , E I Karamisheva  1 , V V Delektorskaya  1 , N E Kushlinskii  1
Affiliations

Chromogranin B in blood serum of patients with neuroendocrine tumors

Nina Vasilyevna Lyubimova et al. Klin Lab Diagn. .

Abstract

Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms from cells of the diffuse neuroendocrine system. Chromogranin B (CgB) is an acidic protein of the granin family, which can be used to detect the tumours of neuroendocrine nature. Analysis of levels and evaluation of the diagnostic efficiency of CgB in the blood serum of patients with NETs of various localizations. Patients with NETs (n=121) without specific treatment were examined. In the study were presented next localizations: 74 - pancreas, 20 - stomach, 12 - large intestine, 15 - other localizations (lungs, mammary gland, prostate gland, NETs with unidentified primary). 54 practically healthy donors were examined as control group. The determination of CgB in blood serum was performed with ELISA method on BEP 2000 analyzer using a standardized test system Human Chromogranin B (USCN, China). CgB levels in common NET group (median 18.9 ng/mL) were statistically significantly higher than in the control group (8.8 ng/mL). The highest median was obtained in group of intestinal NETs (21.2 ng/ml), which exceeded the median of the control group by more than 2.4 times. According to ROC analysis in the common NET group relative to the control group, the area under the curve AUC was 0.88 (95% CI 0.83-0.929). According to cut-off level of CgB - 15.8 ng/ml, the diagnostic sensitivity was 69.4%, with a specificity of 96.3%. The highest diagnostic sensitivity was in the group of the intestinal NETs (75.0%) and pancreas (71.2%). The study showed the significance of CgB as a potential biochemical marker of NETs with various localizations, alternative to CgA.

Keywords: biochemical marker; chromogranin B; neuroendocrine tumors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Oberg K. Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours. Endocr. Relat. Cancer. 2011; 18(1): 17–25.
    1. Aluri V., Dilon J.S. Biochemical testing in neuroendocrine tumors. Endocrinol. Metab. Clin. North Am. 2017; 46(3): 669–77.
    1. Vinik A.I., Silva M.P., Woltering E.A. et al. Biochemical testing for neuroendocrine tumors. Pancreas. 2009; 38(8): 876–89.
    1. Hofland J., Kaltsas G., de Herder W.W. Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms. Endocr. Rev. 2020; 41(2): 371–403.
    1. Cheng Y., Sun Z., Bai C., Yan X., Qin R., Meng C., Ying H. Serum chromogranin A levels for the diagnosis and follow-up of well-differentiated non-functioning neuroendocrine tumors. Tumour Biol. 2016; 37(3): 2863–9.

LinkOut - more resources